Dr. Nicaise Ndembi is the Director of Laboratory Research at IHVN. As a virologist and public health expert, he is applying his wealth of experience in molecular virology to coordinate and carry out quality laboratory research in HIV diversity, resistance to anti-retroviral therapy, genomics epidemiology, emerging and re-emerging infectious diseases amongst other areas.
Dr. Ndembi is also Adjunct Associate Professor, Division of Epidemiology and Prevention at the Institute of Human Virology, University of Maryland School of Medicine, USA. He serves as Collaborative Professor of Virology in the Department of Viral Infection and International Health, Graduate School of Medical Science, Kanazawa University, Japan. and a Research Professor, Global Affairs Section at the same university.
He has actively participated in several scientific advisory panels and as an advisor to Nigeria’s Federal Ministry of Health on HIV drug resistance and control policy. He is a member of the PharmAccess Technical Advisory Board for the Pan-African Study for Evaluation of Resistance (PASER) in Africa (Lancet Infectious Diseases 2012), and a member of the WHO Resistance Network Technical Working Group on Guidelines Development (Lancet 2012).
He is an author/co-author of more than 100 publications in peer reviewed journals and the Editor-in-Chief for the Africa CDC Journal of Public Health in Africa and AIDS Research and Therapy. Dr. Ndembi is also an Associate Editor for Frontiers in Public Health and Section Editor for the African Journal of Laboratory Medicine. He has contributed as a member of numerous international review boards and is a Principal Investigator and Co-Investigator for US National Health Institute (NIH) grants.
Dr. Ndembi is a graduate of Kanazawa University School of Medicine, Department of Viral Infection and International Public Health.